BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 27236302)

  • 41. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer.
    Fulgham PF
    World J Urol; 2018 May; 36(5):713-718. PubMed ID: 29368230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
    Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
    Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
    Dieffenbacher S; Nyarangi-Dix J; Giganti F; Bonekamp D; Kesch C; Müller-Wolf MB; Schütz V; Gasch C; Hatiboglu G; Hauffe M; Stenzinger A; Duensing S; Schlemmer HP; Moore CM; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2021 Jan; 7(1):102-110. PubMed ID: 30878348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.
    Yaxley AJ; Yaxley JW; Thangasamy IA; Ballard E; Pokorny MR
    BJU Int; 2017 Nov; 120 Suppl 3():43-50. PubMed ID: 28749035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiparametric MRI/TRUS Fusion Prostate Biopsy: Advantages of a Transperineal Approach.
    Pepe P; Garufi A; Priolo GD; Pennisi M
    Anticancer Res; 2017 Jun; 37(6):3291-3294. PubMed ID: 28551679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
    Kaufmann S; Mischinger J; Amend B; Rausch S; Adam M; Scharpf M; Fend F; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
    World J Urol; 2017 Jul; 35(7):1023-1029. PubMed ID: 27847972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
    Muller BG; Kaushal A; Sankineni S; Lita E; Hoang AN; George AK; Rais-Bahrami S; Kruecker J; Yan P; Xu S; de la Rosette JJ; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Urol Oncol; 2015 Oct; 33(10):425.e1-425.e6. PubMed ID: 26259666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
    Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
    Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
    Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
    Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?
    Abd-Alazeez M; Ahmed HU; Arya M; Allen C; Dikaios N; Freeman A; Emberton M; Kirkham A
    Urol Oncol; 2014 Aug; 32(6):741-7. PubMed ID: 24981993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

  • 56. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
    Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Segmented diffusion-weighted imaging of the prostate: Application to transperineal in-bore 3T MR image-guided targeted biopsy.
    Fedorov A; Tuncali K; Panych LP; Fairhurst J; Hassanzadeh E; Seethamraju RT; Tempany CM; Maier SE
    Magn Reson Imaging; 2016 Oct; 34(8):1146-54. PubMed ID: 27240900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.